Please login to the form below

Not currently logged in
Email:
Password:

New accounts October 2007

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period September to October 2007 inclusive

Advertising agencies

Client

Product

Therapeutic area

Winning agency

Abbott

Humira

NPD

Saatchi & Saatchi Healthcare

Basilea

N/A

Corporate

Cherry Advertising

Derma UK

Nail-it!

Anti-fungal

Life

Ferring Pharmaceuticals (Europe)

N/A

N/A

Roundhouse HealthAd

Genzyme

Thyrogen

Thyroid disorders

Cherry Advertising

Intervet

Bovipast RSP

Anti-infective

Cherry Advertising

Intervet

Cephaguard

Bacterial infections

Cherry Advertising

MY Healthcare

LeafletXtra

n/a

Life

Novo Nordisk

Insulin delivery

NPD

Saatchi & Saatchi Healthcare

ProStrakan

Rectogesic

Gastrointestinal

Life

ProStrakan

Isotard XL

Cardiovascular

Life

ProStrakan

Tabphyn MR

Genito-urinary

Life

ProStrakan

Droperidol

Anti-emetic

Life

 

PR & med ed

Client

Product

Therapeutic area

Winning agency

ApaTech

Actifuse

Bone grafting

Jango Communications

AstraZeneca

N/A

Respiratory

Right Angle Communications

Bayer

Avelox

Anti-infectives

Grey Healthcare

BTG

Media relations programme

Corporate

Northbank Communications

GE Healthcare

Hexvix

Bladder cancer

Succinct Communications

GE Healthcare

New product

Human amyloid imaging

Succinct Communications

Grunenthal UK

n/a

Media planning & buying

Medical Media Services

Novartis

Cubicin

Anti-infective

Shire Health PR

sanofi-aventis

Taxotere

Oncology; managed entry

Succinct Communications

Spire Healthcare

n/a

Media planning & buying

Medical Media Services

Stiefel Laboratories

Acne portfolio

Dermatology

Munro & Forster

Teva

Oncology portfolio

Oncology

Succinct Communications

16th October 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics